Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023

Rhea-AI Summary

Integra LifeSciences Holdings Corporation (NASDAQ: IART) will announce its fourth quarter 2022 financial results on February 22, 2023, before the market opens. A conference call with the management team is scheduled for 8:30 a.m. ET on the same day. This event will be accessible via a live webcast on the company's investor website. Integra is recognized as a leader in regenerative tissue technologies and neurosurgical solutions, providing a wide range of high-quality products to enhance patient care. Investors can find further details and register for the call on their official site.

Positive

• Scheduled earnings release may indicate stable business outlook.
• Company continues strong leadership position in medical technology.

Negative

• None.

PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial results on Wednesday, February 22, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event’s start. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Integra LifeSciences

Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

Integra LifeSciences Holdings Corporation

 

FAQ

When will Integra LifeSciences release its financial results for Q4 2022?

Integra LifeSciences will release its Q4 2022 financial results on February 22, 2023.

What time is the conference call for Integra LifeSciences scheduled?

The conference call is scheduled for 8:30 a.m. ET on February 22, 2023.

Where can I watch the webcast for Integra LifeSciences earnings call?

The webcast will be available on the Investors section of Integra's website.

What is the stock symbol for Integra LifeSciences?

Integra LifeSciences trades under the stock symbol IART.